Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ewerth

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
European Journal of Clinical Pharmacology|January 1, 1991
Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolismK Einarsson, S Ericsson, S Ewerth, et al.
Journal of Lipid Research|August 1, 1987
On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humansI Björkhem, E Reihnér, B Angelin, et al.
European Journal of Clinical Investigation|August 1, 1988
Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatmentS Sahlin, J Ahlberg, B Angelin, et al.
Gastroenterology|April 1, 1991
Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileumJ E Akerlund, E Reihnér, B Angelin, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 1, 1983
Metabolic effects of four intravenous nutritional regimens after elective surgery. I. Clinical data and biochemistryS Ewerth, L G Allgen, P Fürst, et al.
The New England Journal of Medicine|July 26, 1990
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterolE Reihnér, M Rudling, D Ståhlberg, et al.
Fortschritte Der Medizin|March 20, 1991
[Effect of pravastatin on hepatic cholesterol metabolism]E Reihnér, M Rudling, D Ståhlberg, et al.
Gastroenterology|November 1, 1992
Hepatic cholesterol metabolism in estrogen-treated menB Angelin, H Olivecrona, E Reihnér, et al.
International Journal of Oncology|May 10, 2011
Different dose regimens of the mouse monoclonal-antibody 17-1a for therapy of patients with metastatic colorectal-carcinomaP Ragnhammar, J Frodin, A Hjelm, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Journal of Clinical Pharmacology|January 1, 1991
Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolismK Einarsson, S Ericsson, S Ewerth, et al.
Journal of Lipid Research|August 1, 1987
On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humansI Björkhem, E Reihnér, B Angelin, et al.
European Journal of Clinical Investigation|August 1, 1988
Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatmentS Sahlin, J Ahlberg, B Angelin, et al.
Gastroenterology|April 1, 1991
Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileumJ E Akerlund, E Reihnér, B Angelin, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 1, 1983
Metabolic effects of four intravenous nutritional regimens after elective surgery. I. Clinical data and biochemistryS Ewerth, L G Allgen, P Fürst, et al.
The New England Journal of Medicine|July 26, 1990
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterolE Reihnér, M Rudling, D Ståhlberg, et al.
Fortschritte Der Medizin|March 20, 1991
[Effect of pravastatin on hepatic cholesterol metabolism]E Reihnér, M Rudling, D Ståhlberg, et al.
Gastroenterology|November 1, 1992
Hepatic cholesterol metabolism in estrogen-treated menB Angelin, H Olivecrona, E Reihnér, et al.
International Journal of Oncology|May 10, 2011
Different dose regimens of the mouse monoclonal-antibody 17-1a for therapy of patients with metastatic colorectal-carcinomaP Ragnhammar, J Frodin, A Hjelm, et al.
Pageof 6